• Citer

Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial

par Cortes, Javier;Velikova, Galina;Hudgens, Stacie;Twelves, Chris;Perez, Edith A;Awada, Ahmad ;Yelle, Louise;McCutcheon, Susan;Kaufman, Peter P.A.;Forsythe, Anna
Référence Breast cancer research and treatment, 154, 3, page (509-520)
Publication Publié, 2015-12

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial
Auteur:	Cortes, Javier; Velikova, Galina; Hudgens, Stacie; Twelves, Chris; Perez, Edith A; Awada, Ahmad; Yelle, Louise; McCutcheon, Susan; Kaufman, Peter P.A.; Forsythe, Anna
Informations sur la publication:	Breast cancer research and treatment, 154, 3, page (509-520)
Statut de publication:	Publié, 2015-12
Sujet CREF:	Cancérologie
Mots-clés:	Breast cancer
	Eribulin
	Minimally important difference
	Quality of life
	Side effects
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0167-6806
	info:doi/10.1007/s10549-015-3633-7
	info:scp/84948387971